ICARES Medicus, Inc. (TPEX:6612)
73.90
-1.00 (-1.34%)
Dec 31, 2025, 2:31 PM CST
ICARES Medicus Market Cap
ICARES Medicus has a market cap or net worth of 3.5 billion as of December 31, 2025. Its market cap has decreased by -33.39% in one year.
Market Cap
3.50B
Enterprise Value
3.71B
Revenue
1.09B
Ranking
n/a
PE Ratio
55.06
Stock Price
73.90
Market Cap Chart
Since December 27, 2016, ICARES Medicus's market cap has increased from 1.51B to 3.50B, an increase of 131.13%. That is a compound annual growth rate of 9.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 3.50B | -33.66% |
| Dec 31, 2024 | 5.28B | 6.98% |
| Dec 29, 2023 | 4.93B | 77.87% |
| Dec 30, 2022 | 2.77B | 18.70% |
| Dec 30, 2021 | 2.34B | 11.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 240.39B |
| PharmaEssentia | 173.83B |
| Lotus Pharmaceutical | 74.42B |
| Heron Neutron Medical | 70.65B |
| Bora Pharmaceuticals Co., LTD. | 60.52B |
| Lin BioScience | 32.84B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 31.06B |